ST

STERIS plcNYSE STE Stock Report

Last reporting period 30 Sep, 2024

Updated 13 Nov, 2024

Last price

Market cap $B

23.494

Large

Exchange

XNYS - New York Stock Exchange, Inc

STE Stock Analysis

ST

Neutral

Based on Eyestock quantitative analysis, STE`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

53/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-13.4 %

Undervalued

Market cap $B

23.494

Dividend yield

0.89 %

Shares outstanding

99.284 B

STERIS Plc engages in the provision of healthcare and life science product and service solutions. The Company’s segments include Healthcare, Applied Sterilization Technologies, Life Sciences and Dental. The Healthcare segment focused on sterile processing departments and procedural centers, such as operating rooms and renal dialysis centers. The firm offers a mix of consumable products, such as detergents, gastrointestinal endoscopy accessories, barrier product solutions, and other products and services, including equipment installation and maintenance, microbial reduction of medical devices, dental instruments and tools, instrument and scope repair, laboratory testing services, outsourced reprocessing, and capital equipment products, such as sterilizers and surgical tables, automated endoscope reprocesses, and connectivity solutions such as operating room integration. The company also offers sterility assurance and barrier products, biocontamination services and equipment maintenance services.

View Section: Eyestock Rating